MedPath

Atropine Sulfate

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for Initial U.S. Approval: 1960

Approved
Approval ID

09d086f2-db9a-5e15-e063-6394a90abe18

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 10, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ATROPINE SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7312
Application NumberANDA216120
Product Classification
M
Marketing Category
C73584
G
Generic Name
ATROPINE SULFATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 10, 2023
FDA Product Classification

INGREDIENTS (5)

SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
ATROPINE SULFATEActive
Quantity: 0.4 mg in 1 mL
Code: 03J5ZE7KA5
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.